Regulatory Filings • Mar 16, 2018
Regulatory Filings
Open in ViewerOpens in native device viewer
Brussels, 16 March 2018
Yesterday, KBC (through DZI Insurance, its Bulgarian subsidiary) completed the acquisition of MetLife's 40% stake in UBB-MetLife Life Insurance Company AD, a life insurance joint venture between United Bulgarian Bank ("UBB") and MetLife ("UBB-MetLife"). The deal was announced on 29 December 2017 and received regulatory approval on 9 March 2018. Its financial impact is immaterial for KBC.
Following this deal, KBC will be able to distribute DZI life and non-life products through UBB's bank branches, thus enabling it to fully roll out its bank-insurance approach in Bulgaria, one of KBC's core markets.
DZI and UBB-MetLife's aggregate share of the Bulgarian life insurance market will be 21%. Together with UBB-CIBANK, they will strengthen KBC's reference position in bank-insurance in Bulgaria, a country that boasts strong macroeconomic fundamentals while still offering potential for further penetration in financial services.
Johan Thijs, KBC Group CEO said: "Acquiring the remaining stake in the UBB-MetLife joint venture confirms our position as a strong, local market player that is able to offer a full range of bank-insurance products to our Bulgarian customers in an omni-channel environment.
It will undoubtedly help in making UBB and DZI a genuine reference bank-insurance group in Bulgaria, which will ultimately benefit its customers, employees and all other stakeholders."
Havenlaan 2 – 1080 Brussels Viviane Huybrecht General Manager of Corporate Communication KBC Group Spokesperson Tel.: + 32 2 429 85 45
Press Office Tel. + 32 2 429 65 01 Stef Leunens Tel. + 32 2 429 29 15 Ilse De Muyer E-mail: [email protected]
Check this document's authenticity at www.kbc.com/en
KBC press releases are available at www.kbc.com Follow us on www.twitter.com/kbc\_group
Stay up-to-date on all innovative solutions at www.kbc.com/innovation.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.